‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent
WASHINGTON, DC—Three-year outcomes from the ABSORB II trial, a time point in which the Absorb GT1 bioresorbable vascular scaffold should be degraded, did not result in an improvement in vasomotor tone ...
WASHINGTON, DC—Two-year results from the ABSORB III study presented today at the American College of Cardiology 2017 Scientific Session show that the Absorb GT1 bioresorbable vascular scaffold (BVS, ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — The Absorb bioresorbable scaffold demonstrated overall clinical outcomes comparable to those of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results